Tech Mahindra to roll out salary hikes in early 2021 in phased manner

This is in line with what Tech Mahindra's larger peers have done. TCS, Wipro, Infosys and HCL Tech have announced salary hike for employees, some rolling them out effective October 1 and others effective January 2021.

Moneycontrol News

October 23, 2020 / 18:18 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Tech Mahindra will roll out salary hikes in a phased manner in 2021 starting with its junior-most employees.

CP Gurnani, CEO, Tech Mahindra, said in an earnings call on October 23, “We are looking at early 2021 for appraisal and salary hikes. But the management team has not really sat down to decide the quantum of hikes.”

“But it is very clear that it will be rolled out and it will be staggered,” he said.

The way it is going to work out, Gurnani explained, is that the junior-most employees will get the salary hike the fastest and the senior-most employees will get it later. “But it is part of my budget and part of my planning to do salary hikes for junior-most employees in FY21 (before March 2021) and for the rest in calendar year 2021 (before December 2021)," he added.

This is in line with what its larger peers have done. All of its peers -- TCS, Wipro, Infosys and HCL Tech -- have announced salary hike for employees, some rolling them out effective October 1 and others effective January 2021.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show